November 15, 2011

German drug maker Boehringer Ingelheim Pharmaceuticals invested more than $350 million in its U.S. operations this year, the company said Tuesday.

October 10, 2011

The Food and Drug Administration has approved a new product for chronic obstructive pulmonary disease made by Boehringer Ingelheim Pharmaceuticals, the drug maker said.

October 6, 2011

Gilead Sciences has signed an agreement with Boehringer Ingelheim to gain exclusive worldwide rights to research, develop and commercialize BI's novel anti-retroviral compounds.

September 16, 2011

A drug made by Boehringer Ingelheim and Eli Lilly showed "meaningful and durable" reductions in blood sugar in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented Friday at a conference in Europe.

September 8, 2011

Boehringer Ingelheim and Eli Lilly will present data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes in Lisbon, Portugal.

June 20, 2011

Just after the approval of their new treatment for Type 2 diabetes, Eli Lilly and Boehringer Ingelheim plan to present data in more than two dozen presentations at the American Diabetes Association Scientific Sessions starting this week.

June 15, 2011

A new oral medication for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim has become available in pharmacies, the companies said Wednesday.

April 5, 2011

The Food and Drug Administration has approved Boehringer Ingelheim Pharmaceuticals' single-pill antiretroviral for HIV-1 patients, BI said Tuesday.

March 17, 2011

To help promote the third annual St. Louis Undy 5000 5K run on March 26, the Colon Cancer Alliance is introducing the “Parade of Undies” fashion show, sponsored by Boehringer Ingelheim, the maker of Dulcolax products.

February 11, 2011

Irish biotech company Elan and German drug maker Boehringer Ingelheim will collaborate to develop and manufacture antibody-based medicines.

July 21, 2010

A once-daily formulation of an HIV drug made by Boehringer Ingelheim works as well as...

March 21, 2010

Boehringer-Ingelheim recently introduced its Dulcolax Balance, a fast-dissolving, clear, tasteless powder that combines with water...

December 14, 2009

The ubiquitous universe of social media — comprised of blogs, microblogs, podcasts, social networks, video sharing sites and more — still holds many unanswered questions for some industry marketers. But there's one thing that is certain: Social media is changing the way consumers behave, and companies and brands must embrace and effectively plug into today's social world. Those that don't will be left in the dark. Find out how top retailers like Walgreens, CVS, Target, etc., as well as top industry suppliers like Boehringer Ingelheim, GlaxoSmithKline, Novartis and more, are plugging into the world of social media.